The use of a clinical decision support tool to assess the risk of QT drug–drug interactions in community pharmacies

por Berger, Florine A., van der Sijs, Heleen, van Gelder, Teun, van den Bemt, Patricia M. L. A.
Publicado 2021

Assessment of drug-related problems at the emergency department in older patients living with frailty: pharmacist-led medication reviews within a geriatric care team

por van Nuland, Merel, Butterhoff, Madelon, Verwijmeren, Karin, Berger, Florine, Hogervorst, Vera M., de Jonghe, Annemarieke, van der Linden, Paul D
Publicado 2023

Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice

por Berger, Florine A., van der Sijs, Heleen, Becker, Matthijs L., van Gelder, Teun, van den Bemt, Patricia M. L. A.
Publicado 2020

Differences in CYP3A genotypes of a liver transplant recipient and the donor liver graft and adjustment of tacrolimus dose

por Berger, Florine A., Mulder, Midas B., ten Bosch‐Dijksman, Willemijn, van Schaik, Ron H.N., Coenen, Sandra, de Winter, Brenda C.M.
Publicado 2019

Dynamics of the QTc interval over a 24‐h dose interval after start of intravenous ciprofloxacin or low‐dose erythromycin administration in ICU patients

por Berger, Florine A., van Weteringen, Willem, van der Sijs, Heleen, Hunfeld, Nicole G. M., Bunge, Jeroen J. H., de Groot, Natasja M. S., van den Bemt, Patricia M. L. A., van Gelder, Teun
Publicado 2021

The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors

por Hussaarts, Koen G. A. M., Berger, Florine A., Binkhorst, Lisette, Oomen - de Hoop, Esther, van Leeuwen, Roelof W. F., van Alphen, Robbert J., Mathijssen - van Stein, Daniëlle, de Groot, Natasja M. S., Mathijssen, Ron H. J., van Gelder, Teun
Publicado 2019